America August 25, 2025
AbbVie to Acquire Gilgamesh’s Bretisilocin in $1.2B Psychedelic Bet
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
America August 25, 2025
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
By Rihem Akkouche
America July 10, 2025
In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…
By Rihem Akkouche
America June 27, 2024
Chicago-based pharmaceutical company AbbVie announced Thursday its acquisition of Celsius Therapeutics Inc., a privately held clinical-stage biotechnology firm focused on…
By Rihem Akkouche
America March 25, 2024
In a strategic move that sent shockwaves through the biopharmaceutical industry, AbbVie Inc. announced on Monday its intention to acquire…
By Rihem Akkouche
America November 30, 2023
In a stunning pre-market announcement, AbbVie Inc. has declared its intention to acquire ImmunoGen Inc., a prominent player in cancer…
By Rochdi Rais
Brand Stories August 9, 2020
AbbVie (NYSE: ABBV) agreed to pay $24 million to settle a lawsuit alleging that the biopharmaceutical company committed wrongdoings in…
By Marivic Cabural Summers
Business May 6, 2020
The Federal Trade Commission (FTC) approved AbbVie’s (NYSE: ABBV) proposal to acquire Allergan (NYSE: AGN) for $63 billion after the…
By Marivic Cabural Summers